Global Huntington's Disease Therapeutics Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Description

According to our (Global Info Research) latest study, the global Huntington's Disease Therapeutics market size was valued at US$ 392 million in 2024 and is forecast to a readjusted size of USD 2296 million by 2031 with a CAGR of 29.1% during review period. 
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.,Huntington"s disease is an inherited disease that causes degeneration of nerve cells in the central nervous system (CNS). The disease has a broad impact on functional abilities of the human and usually results in movement and thinking disabilities. Most people with Huntington"s disease develop signs and symptoms in their age of 30 to 40. When disease begins before age 20, the condition is known as juvenile Huntington"s disease.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report is a detailed and comprehensive analysis for global Huntington's Disease Therapeutics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Huntington's Disease Therapeutics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Huntington's Disease Therapeutics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Huntington's Disease Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Huntington's Disease Therapeutics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Huntington's Disease Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Huntington's Disease Therapeutics market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffmann-La Roche, H. Lundbeck, Prana Biotechnology, Teva Pharmaceutical Industries, Horizon Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Huntington's Disease Therapeutics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Antidopaminergics
    Anticonvulsants
    Antipsychotics
    Antidepressants

Market segment by Application
    Hospitals
    Clinics
    Diagnostic Centers

Major players covered
    F. Hoffmann-La Roche
    H. Lundbeck
    Prana Biotechnology
    Teva Pharmaceutical Industries
    Horizon Pharma

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Huntington's Disease Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Huntington's Disease Therapeutics, with price, sales quantity, revenue, and global market share of Huntington's Disease Therapeutics from 2020 to 2025.
Chapter 3, the Huntington's Disease Therapeutics competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Huntington's Disease Therapeutics breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Huntington's Disease Therapeutics market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Huntington's Disease Therapeutics.
Chapter 14 and 15, to describe Huntington's Disease Therapeutics sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Huntington's Disease Therapeutics Consumption Value by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Antidopaminergics
        1.3.3 Anticonvulsants
        1.3.4 Antipsychotics
        1.3.5 Antidepressants
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Huntington's Disease Therapeutics Consumption Value by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Hospitals
        1.4.3 Clinics
        1.4.4 Diagnostic Centers
    1.5 Global Huntington's Disease Therapeutics Market Size & Forecast
        1.5.1 Global Huntington's Disease Therapeutics Consumption Value (2020 & 2024 & 2031)
        1.5.2 Global Huntington's Disease Therapeutics Sales Quantity (2020-2031)
        1.5.3 Global Huntington's Disease Therapeutics Average Price (2020-2031)

2 Manufacturers Profiles
    2.1 F. Hoffmann-La Roche
        2.1.1 F. Hoffmann-La Roche Details
        2.1.2 F. Hoffmann-La Roche Major Business
        2.1.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Product and Services
        2.1.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 F. Hoffmann-La Roche Recent Developments/Updates
    2.2 H. Lundbeck
        2.2.1 H. Lundbeck Details
        2.2.2 H. Lundbeck Major Business
        2.2.3 H. Lundbeck Huntington's Disease Therapeutics Product and Services
        2.2.4 H. Lundbeck Huntington's Disease Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 H. Lundbeck Recent Developments/Updates
    2.3 Prana Biotechnology
        2.3.1 Prana Biotechnology Details
        2.3.2 Prana Biotechnology Major Business
        2.3.3 Prana Biotechnology Huntington's Disease Therapeutics Product and Services
        2.3.4 Prana Biotechnology Huntington's Disease Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Prana Biotechnology Recent Developments/Updates
    2.4 Teva Pharmaceutical Industries
        2.4.1 Teva Pharmaceutical Industries Details
        2.4.2 Teva Pharmaceutical Industries Major Business
        2.4.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product and Services
        2.4.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
    2.5 Horizon Pharma
        2.5.1 Horizon Pharma Details
        2.5.2 Horizon Pharma Major Business
        2.5.3 Horizon Pharma Huntington's Disease Therapeutics Product and Services
        2.5.4 Horizon Pharma Huntington's Disease Therapeutics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Horizon Pharma Recent Developments/Updates

3 Competitive Environment: Huntington's Disease Therapeutics by Manufacturer
    3.1 Global Huntington's Disease Therapeutics Sales Quantity by Manufacturer (2020-2025)
    3.2 Global Huntington's Disease Therapeutics Revenue by Manufacturer (2020-2025)
    3.3 Global Huntington's Disease Therapeutics Average Price by Manufacturer (2020-2025)
    3.4 Market Share Analysis (2024)
        3.4.1 Producer Shipments of Huntington's Disease Therapeutics by Manufacturer Revenue ($MM) and Market Share (%): 2024
        3.4.2 Top 3 Huntington's Disease Therapeutics Manufacturer Market Share in 2024
        3.4.3 Top 6 Huntington's Disease Therapeutics Manufacturer Market Share in 2024
    3.5 Huntington's Disease Therapeutics Market: Overall Company Footprint Analysis
        3.5.1 Huntington's Disease Therapeutics Market: Region Footprint
        3.5.2 Huntington's Disease Therapeutics Market: Company Product Type Footprint
        3.5.3 Huntington's Disease Therapeutics Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Huntington's Disease Therapeutics Market Size by Region
        4.1.1 Global Huntington's Disease Therapeutics Sales Quantity by Region (2020-2031)
        4.1.2 Global Huntington's Disease Therapeutics Consumption Value by Region (2020-2031)
        4.1.3 Global Huntington's Disease Therapeutics Average Price by Region (2020-2031)
    4.2 North America Huntington's Disease Therapeutics Consumption Value (2020-2031)
    4.3 Europe Huntington's Disease Therapeutics Consumption Value (2020-2031)
    4.4 Asia-Pacific Huntington's Disease Therapeutics Consumption Value (2020-2031)
    4.5 South America Huntington's Disease Therapeutics Consumption Value (2020-2031)
    4.6 Middle East & Africa Huntington's Disease Therapeutics Consumption Value (2020-2031)

5 Market Segment by Type
    5.1 Global Huntington's Disease Therapeutics Sales Quantity by Type (2020-2031)
    5.2 Global Huntington's Disease Therapeutics Consumption Value by Type (2020-2031)
    5.3 Global Huntington's Disease Therapeutics Average Price by Type (2020-2031)

6 Market Segment by Application
    6.1 Global Huntington's Disease Therapeutics Sales Quantity by Application (2020-2031)
    6.2 Global Huntington's Disease Therapeutics Consumption Value by Application (2020-2031)
    6.3 Global Huntington's Disease Therapeutics Average Price by Application (2020-2031)

7 North America
    7.1 North America Huntington's Disease Therapeutics Sales Quantity by Type (2020-2031)
    7.2 North America Huntington's Disease Therapeutics Sales Quantity by Application (2020-2031)
    7.3 North America Huntington's Disease Therapeutics Market Size by Country
        7.3.1 North America Huntington's Disease Therapeutics Sales Quantity by Country (2020-2031)
        7.3.2 North America Huntington's Disease Therapeutics Consumption Value by Country (2020-2031)
        7.3.3 United States Market Size and Forecast (2020-2031)
        7.3.4 Canada Market Size and Forecast (2020-2031)
        7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe
    8.1 Europe Huntington's Disease Therapeutics Sales Quantity by Type (2020-2031)
    8.2 Europe Huntington's Disease Therapeutics Sales Quantity by Application (2020-2031)
    8.3 Europe Huntington's Disease Therapeutics Market Size by Country
        8.3.1 Europe Huntington's Disease Therapeutics Sales Quantity by Country (2020-2031)
        8.3.2 Europe Huntington's Disease Therapeutics Consumption Value by Country (2020-2031)
        8.3.3 Germany Market Size and Forecast (2020-2031)
        8.3.4 France Market Size and Forecast (2020-2031)
        8.3.5 United Kingdom Market Size and Forecast (2020-2031)
        8.3.6 Russia Market Size and Forecast (2020-2031)
        8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific
    9.1 Asia-Pacific Huntington's Disease Therapeutics Sales Quantity by Type (2020-2031)
    9.2 Asia-Pacific Huntington's Disease Therapeutics Sales Quantity by Application (2020-2031)
    9.3 Asia-Pacific Huntington's Disease Therapeutics Market Size by Region
        9.3.1 Asia-Pacific Huntington's Disease Therapeutics Sales Quantity by Region (2020-2031)
        9.3.2 Asia-Pacific Huntington's Disease Therapeutics Consumption Value by Region (2020-2031)
        9.3.3 China Market Size and Forecast (2020-2031)
        9.3.4 Japan Market Size and Forecast (2020-2031)
        9.3.5 South Korea Market Size and Forecast (2020-2031)
        9.3.6 India Market Size and Forecast (2020-2031)
        9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
        9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America
    10.1 South America Huntington's Disease Therapeutics Sales Quantity by Type (2020-2031)
    10.2 South America Huntington's Disease Therapeutics Sales Quantity by Application (2020-2031)
    10.3 South America Huntington's Disease Therapeutics Market Size by Country
        10.3.1 South America Huntington's Disease Therapeutics Sales Quantity by Country (2020-2031)
        10.3.2 South America Huntington's Disease Therapeutics Consumption Value by Country (2020-2031)
        10.3.3 Brazil Market Size and Forecast (2020-2031)
        10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa
    11.1 Middle East & Africa Huntington's Disease Therapeutics Sales Quantity by Type (2020-2031)
    11.2 Middle East & Africa Huntington's Disease Therapeutics Sales Quantity by Application (2020-2031)
    11.3 Middle East & Africa Huntington's Disease Therapeutics Market Size by Country
        11.3.1 Middle East & Africa Huntington's Disease Therapeutics Sales Quantity by Country (2020-2031)
        11.3.2 Middle East & Africa Huntington's Disease Therapeutics Consumption Value by Country (2020-2031)
        11.3.3 Turkey Market Size and Forecast (2020-2031)
        11.3.4 Egypt Market Size and Forecast (2020-2031)
        11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
        11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics
    12.1 Huntington's Disease Therapeutics Market Drivers
    12.2 Huntington's Disease Therapeutics Market Restraints
    12.3 Huntington's Disease Therapeutics Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Huntington's Disease Therapeutics and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Huntington's Disease Therapeutics
    13.3 Huntington's Disease Therapeutics Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Huntington's Disease Therapeutics Typical Distributors
    14.3 Huntington's Disease Therapeutics Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Huntington's Disease Therapeutics Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Huntington's Disease Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
 Table 4. F. Hoffmann-La Roche Major Business
 Table 5. F. Hoffmann-La Roche Huntington's Disease Therapeutics Product and Services
 Table 6. F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 7. F. Hoffmann-La Roche Recent Developments/Updates
 Table 8. H. Lundbeck Basic Information, Manufacturing Base and Competitors
 Table 9. H. Lundbeck Major Business
 Table 10. H. Lundbeck Huntington's Disease Therapeutics Product and Services
 Table 11. H. Lundbeck Huntington's Disease Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 12. H. Lundbeck Recent Developments/Updates
 Table 13. Prana Biotechnology Basic Information, Manufacturing Base and Competitors
 Table 14. Prana Biotechnology Major Business
 Table 15. Prana Biotechnology Huntington's Disease Therapeutics Product and Services
 Table 16. Prana Biotechnology Huntington's Disease Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 17. Prana Biotechnology Recent Developments/Updates
 Table 18. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
 Table 19. Teva Pharmaceutical Industries Major Business
 Table 20. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product and Services
 Table 21. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 22. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 23. Horizon Pharma Basic Information, Manufacturing Base and Competitors
 Table 24. Horizon Pharma Major Business
 Table 25. Horizon Pharma Huntington's Disease Therapeutics Product and Services
 Table 26. Horizon Pharma Huntington's Disease Therapeutics Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 27. Horizon Pharma Recent Developments/Updates
 Table 28. Global Huntington's Disease Therapeutics Sales Quantity by Manufacturer (2020-2025) & (K Units)
 Table 29. Global Huntington's Disease Therapeutics Revenue by Manufacturer (2020-2025) & (USD Million)
 Table 30. Global Huntington's Disease Therapeutics Average Price by Manufacturer (2020-2025) & (USD/Unit)
 Table 31. Market Position of Manufacturers in Huntington's Disease Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 32. Head Office and Huntington's Disease Therapeutics Production Site of Key Manufacturer
 Table 33. Huntington's Disease Therapeutics Market: Company Product Type Footprint
 Table 34. Huntington's Disease Therapeutics Market: Company Product Application Footprint
 Table 35. Huntington's Disease Therapeutics New Market Entrants and Barriers to Market Entry
 Table 36. Huntington's Disease Therapeutics Mergers, Acquisition, Agreements, and Collaborations
 Table 37. Global Huntington's Disease Therapeutics Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
 Table 38. Global Huntington's Disease Therapeutics Sales Quantity by Region (2020-2025) & (K Units)
 Table 39. Global Huntington's Disease Therapeutics Sales Quantity by Region (2026-2031) & (K Units)
 Table 40. Global Huntington's Disease Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
 Table 41. Global Huntington's Disease Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
 Table 42. Global Huntington's Disease Therapeutics Average Price by Region (2020-2025) & (USD/Unit)
 Table 43. Global Huntington's Disease Therapeutics Average Price by Region (2026-2031) & (USD/Unit)
 Table 44. Global Huntington's Disease Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
 Table 45. Global Huntington's Disease Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
 Table 46. Global Huntington's Disease Therapeutics Consumption Value by Type (2020-2025) & (USD Million)
 Table 47. Global Huntington's Disease Therapeutics Consumption Value by Type (2026-2031) & (USD Million)
 Table 48. Global Huntington's Disease Therapeutics Average Price by Type (2020-2025) & (USD/Unit)
 Table 49. Global Huntington's Disease Therapeutics Average Price by Type (2026-2031) & (USD/Unit)
 Table 50. Global Huntington's Disease Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
 Table 51. Global Huntington's Disease Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
 Table 52. Global Huntington's Disease Therapeutics Consumption Value by Application (2020-2025) & (USD Million)
 Table 53. Global Huntington's Disease Therapeutics Consumption Value by Application (2026-2031) & (USD Million)
 Table 54. Global Huntington's Disease Therapeutics Average Price by Application (2020-2025) & (USD/Unit)
 Table 55. Global Huntington's Disease Therapeutics Average Price by Application (2026-2031) & (USD/Unit)
 Table 56. North America Huntington's Disease Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
 Table 57. North America Huntington's Disease Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
 Table 58. North America Huntington's Disease Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
 Table 59. North America Huntington's Disease Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
 Table 60. North America Huntington's Disease Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
 Table 61. North America Huntington's Disease Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
 Table 62. North America Huntington's Disease Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
 Table 63. North America Huntington's Disease Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
 Table 64. Europe Huntington's Disease Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
 Table 65. Europe Huntington's Disease Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
 Table 66. Europe Huntington's Disease Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
 Table 67. Europe Huntington's Disease Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
 Table 68. Europe Huntington's Disease Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
 Table 69. Europe Huntington's Disease Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
 Table 70. Europe Huntington's Disease Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
 Table 71. Europe Huntington's Disease Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
 Table 72. Asia-Pacific Huntington's Disease Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
 Table 73. Asia-Pacific Huntington's Disease Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
 Table 74. Asia-Pacific Huntington's Disease Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
 Table 75. Asia-Pacific Huntington's Disease Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
 Table 76. Asia-Pacific Huntington's Disease Therapeutics Sales Quantity by Region (2020-2025) & (K Units)
 Table 77. Asia-Pacific Huntington's Disease Therapeutics Sales Quantity by Region (2026-2031) & (K Units)
 Table 78. Asia-Pacific Huntington's Disease Therapeutics Consumption Value by Region (2020-2025) & (USD Million)
 Table 79. Asia-Pacific Huntington's Disease Therapeutics Consumption Value by Region (2026-2031) & (USD Million)
 Table 80. South America Huntington's Disease Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
 Table 81. South America Huntington's Disease Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
 Table 82. South America Huntington's Disease Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
 Table 83. South America Huntington's Disease Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
 Table 84. South America Huntington's Disease Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
 Table 85. South America Huntington's Disease Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
 Table 86. South America Huntington's Disease Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
 Table 87. South America Huntington's Disease Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
 Table 88. Middle East & Africa Huntington's Disease Therapeutics Sales Quantity by Type (2020-2025) & (K Units)
 Table 89. Middle East & Africa Huntington's Disease Therapeutics Sales Quantity by Type (2026-2031) & (K Units)
 Table 90. Middle East & Africa Huntington's Disease Therapeutics Sales Quantity by Application (2020-2025) & (K Units)
 Table 91. Middle East & Africa Huntington's Disease Therapeutics Sales Quantity by Application (2026-2031) & (K Units)
 Table 92. Middle East & Africa Huntington's Disease Therapeutics Sales Quantity by Country (2020-2025) & (K Units)
 Table 93. Middle East & Africa Huntington's Disease Therapeutics Sales Quantity by Country (2026-2031) & (K Units)
 Table 94. Middle East & Africa Huntington's Disease Therapeutics Consumption Value by Country (2020-2025) & (USD Million)
 Table 95. Middle East & Africa Huntington's Disease Therapeutics Consumption Value by Country (2026-2031) & (USD Million)
 Table 96. Huntington's Disease Therapeutics Raw Material
 Table 97. Key Manufacturers of Huntington's Disease Therapeutics Raw Materials
 Table 98. Huntington's Disease Therapeutics Typical Distributors
 Table 99. Huntington's Disease Therapeutics Typical Customers


List of Figures
 Figure 1. Huntington's Disease Therapeutics Picture
 Figure 2. Global Huntington's Disease Therapeutics Revenue by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Huntington's Disease Therapeutics Revenue Market Share by Type in 2024
 Figure 4. Antidopaminergics Examples
 Figure 5. Anticonvulsants Examples
 Figure 6. Antipsychotics Examples
 Figure 7. Antidepressants Examples
 Figure 8. Global Huntington's Disease Therapeutics Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 9. Global Huntington's Disease Therapeutics Revenue Market Share by Application in 2024
 Figure 10. Hospitals Examples
 Figure 11. Clinics Examples
 Figure 12. Diagnostic Centers Examples
 Figure 13. Global Huntington's Disease Therapeutics Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 14. Global Huntington's Disease Therapeutics Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 15. Global Huntington's Disease Therapeutics Sales Quantity (2020-2031) & (K Units)
 Figure 16. Global Huntington's Disease Therapeutics Price (2020-2031) & (USD/Unit)
 Figure 17. Global Huntington's Disease Therapeutics Sales Quantity Market Share by Manufacturer in 2024
 Figure 18. Global Huntington's Disease Therapeutics Revenue Market Share by Manufacturer in 2024
 Figure 19. Producer Shipments of Huntington's Disease Therapeutics by Manufacturer Sales ($MM) and Market Share (%): 2024
 Figure 20. Top 3 Huntington's Disease Therapeutics Manufacturer (Revenue) Market Share in 2024
 Figure 21. Top 6 Huntington's Disease Therapeutics Manufacturer (Revenue) Market Share in 2024
 Figure 22. Global Huntington's Disease Therapeutics Sales Quantity Market Share by Region (2020-2031)
 Figure 23. Global Huntington's Disease Therapeutics Consumption Value Market Share by Region (2020-2031)
 Figure 24. North America Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 25. Europe Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 26. Asia-Pacific Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 27. South America Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 28. Middle East & Africa Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 29. Global Huntington's Disease Therapeutics Sales Quantity Market Share by Type (2020-2031)
 Figure 30. Global Huntington's Disease Therapeutics Consumption Value Market Share by Type (2020-2031)
 Figure 31. Global Huntington's Disease Therapeutics Average Price by Type (2020-2031) & (USD/Unit)
 Figure 32. Global Huntington's Disease Therapeutics Sales Quantity Market Share by Application (2020-2031)
 Figure 33. Global Huntington's Disease Therapeutics Revenue Market Share by Application (2020-2031)
 Figure 34. Global Huntington's Disease Therapeutics Average Price by Application (2020-2031) & (USD/Unit)
 Figure 35. North America Huntington's Disease Therapeutics Sales Quantity Market Share by Type (2020-2031)
 Figure 36. North America Huntington's Disease Therapeutics Sales Quantity Market Share by Application (2020-2031)
 Figure 37. North America Huntington's Disease Therapeutics Sales Quantity Market Share by Country (2020-2031)
 Figure 38. North America Huntington's Disease Therapeutics Consumption Value Market Share by Country (2020-2031)
 Figure 39. United States Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 40. Canada Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 41. Mexico Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 42. Europe Huntington's Disease Therapeutics Sales Quantity Market Share by Type (2020-2031)
 Figure 43. Europe Huntington's Disease Therapeutics Sales Quantity Market Share by Application (2020-2031)
 Figure 44. Europe Huntington's Disease Therapeutics Sales Quantity Market Share by Country (2020-2031)
 Figure 45. Europe Huntington's Disease Therapeutics Consumption Value Market Share by Country (2020-2031)
 Figure 46. Germany Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 47. France Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 48. United Kingdom Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 49. Russia Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 50. Italy Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 51. Asia-Pacific Huntington's Disease Therapeutics Sales Quantity Market Share by Type (2020-2031)
 Figure 52. Asia-Pacific Huntington's Disease Therapeutics Sales Quantity Market Share by Application (2020-2031)
 Figure 53. Asia-Pacific Huntington's Disease Therapeutics Sales Quantity Market Share by Region (2020-2031)
 Figure 54. Asia-Pacific Huntington's Disease Therapeutics Consumption Value Market Share by Region (2020-2031)
 Figure 55. China Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 56. Japan Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 57. South Korea Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 58. India Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 59. Southeast Asia Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 60. Australia Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 61. South America Huntington's Disease Therapeutics Sales Quantity Market Share by Type (2020-2031)
 Figure 62. South America Huntington's Disease Therapeutics Sales Quantity Market Share by Application (2020-2031)
 Figure 63. South America Huntington's Disease Therapeutics Sales Quantity Market Share by Country (2020-2031)
 Figure 64. South America Huntington's Disease Therapeutics Consumption Value Market Share by Country (2020-2031)
 Figure 65. Brazil Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 66. Argentina Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 67. Middle East & Africa Huntington's Disease Therapeutics Sales Quantity Market Share by Type (2020-2031)
 Figure 68. Middle East & Africa Huntington's Disease Therapeutics Sales Quantity Market Share by Application (2020-2031)
 Figure 69. Middle East & Africa Huntington's Disease Therapeutics Sales Quantity Market Share by Country (2020-2031)
 Figure 70. Middle East & Africa Huntington's Disease Therapeutics Consumption Value Market Share by Country (2020-2031)
 Figure 71. Turkey Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 72. Egypt Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 73. Saudi Arabia Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 74. South Africa Huntington's Disease Therapeutics Consumption Value (2020-2031) & (USD Million)
 Figure 75. Huntington's Disease Therapeutics Market Drivers
 Figure 76. Huntington's Disease Therapeutics Market Restraints
 Figure 77. Huntington's Disease Therapeutics Market Trends
 Figure 78. Porters Five Forces Analysis
 Figure 79. Manufacturing Cost Structure Analysis of Huntington's Disease Therapeutics in 2024
 Figure 80. Manufacturing Process Analysis of Huntington's Disease Therapeutics
 Figure 81. Huntington's Disease Therapeutics Industrial Chain
 Figure 82. Sales Channel: Direct to End-User vs Distributors
 Figure 83. Direct Channel Pros & Cons
 Figure 84. Indirect Channel Pros & Cons
 Figure 85. Methodology
 Figure 86. Research Process and Data Source

Companies Mentioned

F. Hoffmann-La Roche
H. Lundbeck
Prana Biotechnology
Teva Pharmaceutical Industries
Horizon Pharma